A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma
Clinical trial NCT04321330 · COMPLETED
Trial details
- NCT number
- NCT04321330
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-07
- Primary completion
- 2023-07-16
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.